Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Apr 28, 2021

SELL
$5.68 - $7.87 $56,800 - $78,700
-10,000 Closed
0 $0
Q4 2020

Feb 08, 2021

BUY
$5.25 - $8.56 $52,500 - $85,600
10,000 New
10,000 $69,000
Q2 2020

Jul 31, 2020

SELL
$4.5 - $7.02 $58,500 - $91,260
-13,000 Closed
0 $0
Q1 2020

May 08, 2020

BUY
$2.87 - $5.49 $37,310 - $71,370
13,000 New
13,000 $60,000

Others Institutions Holding CERS

About CERUS CORP


  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $328M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Moloney Securities Asset Management, LLC Portfolio

Follow Moloney Securities Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moloney Securities Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Moloney Securities Asset Management, LLC with notifications on news.